Updated on January 22, 2021 at 5:57 pm
NBCUniversal, Inc.
Infusions of monoclonal antibodies are one of the few treatments with promise to keep people with COVID-19 from getting so sick, they wind up in the emergency room.
Researchers from Baylor University Medical Center recently published findings from their latest study, proving that monoclonal antibodies reduce hospitalizations among patients at high risk of complications from COVID-19.
Dr. Robert Gottlieb of Baylor University Medical Center and a lead author of the study says those given a combination of antibodies in the first few days of their illness had lower levels of virus days later and were less likely to visit the hospital than those given a placebo.